J
Johanna Thomas Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Director of The School of Social Work
faculty
9 h-index
57 pubs
266 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Johanna Thomas's research program investigates the impact of historical trauma on American Indian motherhood, focusing on the Keetoowah experiences of becoming mothers. She also studies the dynamics of providing street medicine to diverse homeless populations, as demonstrated by her work in Hawaii. Thomas has published research on therapeutic interventions, including the role of chromatin alterations in leukemia and solid tumors, and the impact of specific genetic mutations, such as TP53, in elderly Acute Myeloid Leukemia (AML) patients. Her work also explores the tattoo environment as a therapeutic healing space for sexual assault survivors and analyzes transition experiences through the lens of Grand Challenges. Thomas is the Director of The School of Social Work at the University of Arkansas at Fayetteville. Her scholarship metrics include an h-index of 8, 52 total publications, and 243 total citations.
Metrics
- h-index: 9
- Publications: 57
- Citations: 266
Selected Publications
-
Community-centered Care in the Justice System: A Case Study in ACT Adaptation in Rural Communities (2026)
-
Queer Camp in the American South: A Practice Note on Secular Church, Social Work, and Building Inclusivity (2025)
-
Power Through Anonymity: Exploring Barriers to Reporting Sexual Assault Through Analysis of Reddit Data (2024)
-
Assessing the influence of self and collective efficacy on volunteering following a natural disaster (2024)
-
Barriers to Empowerment at the Intersection of Motherhood, TANF, and Intimate Partner Violence (2024)
-
Land allotment, transportation access, and indigenous maternal mental health (2023)
-
The Tattoo Environment as a Therapeutic Healing Space for Sexual Assault Survivors (2023)
-
The dynamics of providing street medicine to a geographically diverse homeless population in Hawaii (2023)
-
Teaming for Transition (2022)
-
American Indian Motherhood and Historical Trauma: Keetoowah Experiences of Becoming Mothers (2022)
-
Service Learning and Self-Efficacy for Master’s Students Engaging in Substance Use Education: A Descriptive Study (2022)
-
“It Would Be Nice If”: Analysis of Transition Experiences Through Grand Challenges (2021)
Collaboration Network
Top Collaborators
December Maxwell
University of Oklahoma (US)
8 shared publications
- American Indian Motherhood and Historical Trauma: Keetoowah Experiences of Becoming Mothers
- The dynamics of providing street medicine to a geographically diverse homeless population in Hawaii
- The Tattoo Environment as a Therapeutic Healing Space for Sexual Assault Survivors
- Land allotment, transportation access, and indigenous maternal mental health
- Assessing the influence of self and collective efficacy on volunteering following a natural disaster
Showing 5 of 8 shared publications
Michael Lübbert
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DE)
8 shared publications
- Therapeutic targeting of chromatin alterations in leukemia and solid tumors
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
- Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation
- Identification of epigenetic modifiers essential for growth and survival of <scp>AML1</scp>/<scp>ETO</scp>‐positive leukemia
Showing 5 of 8 shared publications
Olga Grishina
University of Freiburg (DE)
6 shared publications
- Impact of <i>TP53</i> Mutation Status in Elderly <scp>AML</scp> Patients When Adding All‐<i>Trans</i> Retinoic Acid or Valproic Acid to Decitabine
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
- Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Showing 5 of 6 shared publications
Claudia Schmoor
University of Freiburg (DE)
6 shared publications
- Impact of <i>TP53</i> Mutation Status in Elderly <scp>AML</scp> Patients When Adding All‐<i>Trans</i> Retinoic Acid or Valproic Acid to Decitabine
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
- Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Showing 5 of 6 shared publications
Dietmar Pfeifer
University of Freiburg (DE)
5 shared publications
- Impact of <i>TP53</i> Mutation Status in Elderly <scp>AML</scp> Patients When Adding All‐<i>Trans</i> Retinoic Acid or Valproic Acid to Decitabine
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
- Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Heiko Becker
German Cancer Research Center (DE)
5 shared publications
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
- Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Decider-2: Prospective Randomized Multicenter Phase III Trial of Decitabine and Venetoclax Administered in Combination with All- <i>Trans</i> Retinoic Acid (ATRA) or Placebo in Patients with Acute Myeloid Leukemia Who Are Ineligible for Induction Chemotherapy
Usama‐Ur Rehman
University of Freiburg (DE)
5 shared publications
- Impact of <i>TP53</i> Mutation Status in Elderly <scp>AML</scp> Patients When Adding All‐<i>Trans</i> Retinoic Acid or Valproic Acid to Decitabine
- Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
- Identification of epigenetic modifiers essential for growth and survival of <scp>AML1</scp>/<scp>ETO</scp>‐positive leukemia
- Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study
- Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia
Milena Pantić
University Medical Center Freiburg (DE)
4 shared publications
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Identification of epigenetic modifiers essential for growth and survival of <scp>AML1</scp>/<scp>ETO</scp>‐positive leukemia
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia
Shaun A. Thomas
University of Arkansas at Fayetteville
3 shared publications
In database
- The Tattoo Environment as a Therapeutic Healing Space for Sexual Assault Survivors
- Assessing the influence of self and collective efficacy on volunteering following a natural disaster
- Bodily Autonomy and Trauma: Understanding the Nature of the Association Between Sexual Trauma, an External Locus of Control, and Depressive Symptoms
Justus Duyster
University of Freiburg (DE)
3 shared publications
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Ralph Wäsch
University of Freiburg (DE)
3 shared publications
- Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation
- Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study
- Decider-2: Prospective Randomized Multicenter Phase III Trial of Decitabine and Venetoclax Administered in Combination with All- <i>Trans</i> Retinoic Acid (ATRA) or Placebo in Patients with Acute Myeloid Leukemia Who Are Ineligible for Induction Chemotherapy
Suzanne Kucharczyk
University of Arkansas at Fayetteville (US)
2 shared publications
- “It Would Be Nice If”: Analysis of Transition Experiences Through Grand Challenges
- Teaming for Transition
Sarah R. Leat
University of Memphis (US)
2 shared publications
- The Tattoo Environment as a Therapeutic Healing Space for Sexual Assault Survivors
- Power Through Anonymity: Exploring Barriers to Reporting Sexual Assault Through Analysis of Reddit Data
S. Coad
University of Hawaiʻi at Mānoa (US)
2 shared publications
- The Tattoo Environment as a Therapeutic Healing Space for Sexual Assault Survivors
- Power Through Anonymity: Exploring Barriers to Reporting Sexual Assault Through Analysis of Reddit Data
Nóra Rebeka Jávorniczky
University Medical Center Freiburg (DE)
2 shared publications
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
- Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Similar Researchers
Based on overlapping research topics
Sarah K. Council
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Cancer Treatment and Pharmacology
Health Disparities and Outcomes
Stacy Tiemeyer
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Health Disparities and Outcomes
Trauma and Emergency Care Studies
Mariam F Haji-Hersi
Harding University Main Campus
Cancer Treatment and Pharmacology
Health Disparities and Outcomes
Behavioral Health and Interventions
Melanie Boyd
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Cancer Treatment and Pharmacology
Health Disparities and Outcomes
Chitra Raghunandan
Harding University Main Campus
Maternal and Perinatal Health Interventions
Health Disparities and Outcomes
Behavioral Health and Interventions
Johnna Berryhill
Arkansas State University
Maternal and Perinatal Health Interventions
Cancer Treatment and Pharmacology
Health Disparities and Outcomes